American Regent Recalls Select Adequan Canine and Equine Injection Lots Over Glass Fiber Contamination

American Regent Inc. Animal Health has initiated a nationwide recall of four lots of Adequan® injectable products after internal testing identified visible glass fibers in certain vials. The company said no adverse events have been reported to date.
  • American Regent is recalling two lots of Adequan® Canine and two lots of Adequan® i.m. for horses.
  • The recall follows the detection of visible glass fiber material during internal quality testing.
  • No adverse events related to the recalled products have been reported.
  • The recalled products were distributed nationwide to veterinarians, distributors and online pharmacies.
  • Veterinarians, distributors and consumers are advised to stop using the affected lots and return or discard remaining inventory.

American Regent Inc. Animal Health has announced a nationwide voluntary recall of two lots of Adequan® Canine Injection and two lots of Adequan® i.m. Injection after internal quality testing detected visible glass fibers in retained product samples.

The recall affects Adequan Canine Injection (100 mg/mL, 5 mL multi-dose vials), Lot Nos. 3369 and 25011, and Adequan i.m. Injection (500 mg/5 mL, 5 mL single-dose vials), Lot Nos. 24416 and 25265P. The products were distributed across the United States to veterinary clinics, distributors, wholesalers and online pharmacies between May 2024 and January 2026.

Potential Health Risks

According to the company, intramuscular injection of a product containing glass fibers could cause localized irritation, swelling, inflammation, injection-site pain, infection or abscess formation. American Regent said it has not received any reports of adverse events associated with the recalled lots.

Adequan Canine is indicated for the treatment of non-infectious degenerative or traumatic joint dysfunction in dogs, while Adequan i.m. is approved for treating degenerative or traumatic joint dysfunction and associated lameness in horses. Both products are prescription medications intended for use by or under the direction of a licensed veterinarian.

What Veterinarians and Distributors Should Do

American Regent advises veterinarians, distributors, retailers and consumers not to use the affected lots.

  • Veterinarians and clinics should return unused recalled product to the manufacturer or properly dispose of it.
  • Distributors and retailers should immediately stop distribution and return or discard remaining inventory.
  • Pet owners whose dogs or horses received product from the recalled lots and experience potential adverse effects should contact their veterinarian.

Questions regarding returns, replacements or credits can be directed to American Regent Customer Service at 800-645-1706 or cs@americanregent.com. Suspected adverse events may be reported to American Regent or the FDA’s Center for Veterinary Medicine.

Information sourced from the company’s press release.

Never Miss an Animal Health Story

Sign up for free to receive the latest veterinary news, product announcements, and industry developments.